
PhaseV(פאזה וי ניסויים בע~מ)
PhaseV(פאזה וי ניסויים בע~מ)
Claim
PhaseV is developing a unique set of advanced technologies and innovative statistical methods to revolutionize trial design, execution, and analysis. PhaseV’s technology first assesses the potential impact of adaptive trial design on the proposed study, followed by optimal design and execution. It also completes retrospective analysis to detect hidden signals in clinical trial data and evaluates endpoints and subpopulations to redefine the success or failure of a trial.PhaseV is developing a unique set of advanced technologies and innovative statistical methods to rev Show More
Alpha Score
$ 65.00 M
Alpha Score
61.8
Predictions
Overview
Team
Financials
- Partnerships
Relationships
Locations
Competitors
Comparison
News
Product
Regulatory
Clinical
Patent
Publications
Notes
0and0